ATE429245T1 - Durch mycobacterium tuberculosis und nicht durch bcg exprimierte proteine und ihre verwendung als diagnostische reagenzien und impfstoffe - Google Patents

Durch mycobacterium tuberculosis und nicht durch bcg exprimierte proteine und ihre verwendung als diagnostische reagenzien und impfstoffe

Info

Publication number
ATE429245T1
ATE429245T1 AT00928851T AT00928851T ATE429245T1 AT E429245 T1 ATE429245 T1 AT E429245T1 AT 00928851 T AT00928851 T AT 00928851T AT 00928851 T AT00928851 T AT 00928851T AT E429245 T1 ATE429245 T1 AT E429245T1
Authority
AT
Austria
Prior art keywords
bcg
mycobacterium tuberculosis
vaccines
proteins expressed
diagnostic reagents
Prior art date
Application number
AT00928851T
Other languages
English (en)
Inventor
Maria Gennaro
Original Assignee
Univ New Jersey Med
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22454351&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE429245(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ New Jersey Med filed Critical Univ New Jersey Med
Application granted granted Critical
Publication of ATE429245T1 publication Critical patent/ATE429245T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A61K49/0006—Skin tests, e.g. intradermal testing, test strips, delayed hypersensitivity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/35—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Mycobacteriaceae (F)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52—Assays involving cytokines
    • G01N2333/555—Interferons [IFN]
    • G01N2333/57—IFN-gamma
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/26—Infectious diseases, e.g. generalised sepsis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/863—Mycobacterium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Physiology (AREA)
AT00928851T 1999-05-04 2000-05-04 Durch mycobacterium tuberculosis und nicht durch bcg exprimierte proteine und ihre verwendung als diagnostische reagenzien und impfstoffe ATE429245T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13250599P 1999-05-04 1999-05-04
PCT/US2000/012257 WO2000066157A1 (en) 1999-05-04 2000-05-04 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines

Publications (1)

Publication Number Publication Date
ATE429245T1 true ATE429245T1 (de) 2009-05-15

Family

ID=22454351

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00928851T ATE429245T1 (de) 1999-05-04 2000-05-04 Durch mycobacterium tuberculosis und nicht durch bcg exprimierte proteine und ihre verwendung als diagnostische reagenzien und impfstoffe

Country Status (10)

Country Link
US (12) US7932373B1 (de)
EP (2) EP1214088B1 (de)
JP (1) JP4820489B2 (de)
AT (1) ATE429245T1 (de)
AU (1) AU773268B2 (de)
CA (1) CA2372583C (de)
DE (1) DE60042078D1 (de)
DK (1) DK1214088T3 (de)
ES (1) ES2326257T3 (de)
WO (1) WO2000066157A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE429245T1 (de) 1999-05-04 2009-05-15 Univ New Jersey Med Durch mycobacterium tuberculosis und nicht durch bcg exprimierte proteine und ihre verwendung als diagnostische reagenzien und impfstoffe
EP1278769A2 (de) * 2000-04-19 2003-01-29 Statens Serum Institut Tuberkulose antigene und verfahren zu ihrer anwendung
PT1350839E (pt) * 2002-04-05 2010-08-12 Pasteur Institut Identificação de regiões rd1 e rd5 associadas a virulência que permitam o desenvolvimento de vacinas melhoradas de m. bovis bcg e m. microti
AU2003224313A1 (en) * 2002-04-27 2003-11-17 The Secretary Of State For Environment, Food And Rural Affairs Mycobacterial antigens and uses thereof
GB0229444D0 (en) * 2002-12-18 2003-01-22 Royal Free Hampstead Nhs Trust Diagnostic method and assay kit
EP2889041A1 (de) 2005-07-26 2015-07-01 Rutgers, The State University of New Jersey Reagenzkit für einen Tuberkulosetest
US8465753B2 (en) * 2007-04-23 2013-06-18 Robert J. Greenstein Combination vaccines against Mycobacterium sp. and methods of using the same
EP2441493B1 (de) * 2006-03-14 2014-05-07 Oregon Health and Science University Verfahren zur Erzeugung einer Immunantwort auf Tuberculosis
GB0618127D0 (en) * 2006-09-14 2006-10-25 Isis Innovation Biomarker
CA2668100C (en) * 2006-11-01 2014-12-23 Immport Therapeutics, Inc. Compositions and methods for immunodominant antigens
ES2335177B1 (es) * 2008-09-19 2011-02-28 Archivel Farma, S.L. Agente inmunoterapeutico apropiado para la profilaxis primaria de la tuberculosis.
EP2812704A4 (de) * 2012-02-07 2016-03-23 Intuitive Biosciences Inc Mycobakteriumstuberkulose-spezifische peptide zur erkennung einer infektion oder immunisierung nichtmenschlicher primaten
CN104628834B (zh) * 2015-01-23 2016-03-23 中国疾病预防控制中心传染病预防控制所 一种结核感染t细胞免疫检测抗原及其应用
WO2018111536A1 (en) 2016-12-14 2018-06-21 Becton, Dickinson And Company Methods and compositions for obtaining a tuberculosis assessment in a subject

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977263A (en) 1992-12-10 1999-11-02 3M Innovative Properties Company Thermal transfer compositions, articles and graphic articles made with same
US6290969B1 (en) 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
DE69636075D1 (de) * 1995-09-01 2006-06-01 Corixa Corp Verbindungen und verfahren zur diagnose von tuberkulose
TR200901109T1 (tr) * 1995-09-01 2012-02-21 Corixa Corporation Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
KR100395295B1 (ko) 1995-09-08 2003-11-22 텍스틸마 악티엔게젤샤프트 직기
CZ126699A3 (cs) * 1996-10-11 1999-09-15 Corixa Corporation Polypeptid obsahující antigenní část rozpustného antigenu M. tuberculosis nebo variantu uvedeného antigenu, molekula DNA kódující tento polypeptid, expresivní vektor, hostitelská buňka, způsoby diagnostiky infekce M. tuberculosis a diagnostické kity
CA2285625C (en) * 1997-04-02 2015-06-30 Statens Serum Institut Nucleic acid fragments and polypeptide fragments derived from m. tuberculosis
EP1003870A1 (de) 1997-07-16 2000-05-31 Institut Pasteur Polynukleotid, das für das lhp protein aus mycobacterium tuberculosis kodiert, dessen biologisch aktive fragmente, und verfahren zu deren verwendung
US6291190B1 (en) * 1998-08-25 2001-09-18 The Board Of Trustees Of The Leland Stanford Junior University Molecular differences between species of the M. tuberculosis complex
ATE429245T1 (de) 1999-05-04 2009-05-15 Univ New Jersey Med Durch mycobacterium tuberculosis und nicht durch bcg exprimierte proteine und ihre verwendung als diagnostische reagenzien und impfstoffe
EP1278769A2 (de) 2000-04-19 2003-01-29 Statens Serum Institut Tuberkulose antigene und verfahren zu ihrer anwendung
AU2003224313A1 (en) 2002-04-27 2003-11-17 The Secretary Of State For Environment, Food And Rural Affairs Mycobacterial antigens and uses thereof
US20070024122A1 (en) * 2005-07-27 2007-02-01 Steve Belson System and method for a distributed front end rectifier power system

Also Published As

Publication number Publication date
CA2372583C (en) 2012-07-10
US20070224122A1 (en) 2007-09-27
US8021832B2 (en) 2011-09-20
AU4702300A (en) 2000-11-17
EP1214088B1 (de) 2009-04-22
JP4820489B2 (ja) 2011-11-24
US20140220600A1 (en) 2014-08-07
JP2003519467A (ja) 2003-06-24
US20130149719A1 (en) 2013-06-13
EP1214088A1 (de) 2002-06-19
US9482671B2 (en) 2016-11-01
US8992942B2 (en) 2015-03-31
US7709211B2 (en) 2010-05-04
US9844604B2 (en) 2017-12-19
US20160169888A1 (en) 2016-06-16
AU773268B2 (en) 2004-05-20
ES2326257T3 (es) 2009-10-06
EP1214088A4 (de) 2003-06-11
US7579141B2 (en) 2009-08-25
US20110052637A1 (en) 2011-03-03
DK1214088T3 (da) 2009-08-24
US9782495B2 (en) 2017-10-10
US8623609B2 (en) 2014-01-07
EP2087906A1 (de) 2009-08-12
US20120107247A1 (en) 2012-05-03
WO2000066157A1 (en) 2000-11-09
US8974800B2 (en) 2015-03-10
US20070224123A1 (en) 2007-09-27
US9238066B2 (en) 2016-01-19
US20100016415A1 (en) 2010-01-21
US20130251739A1 (en) 2013-09-26
AU773268C (en) 2000-11-17
US20160153986A1 (en) 2016-06-02
US20170043038A1 (en) 2017-02-16
US7932373B1 (en) 2011-04-26
CA2372583A1 (en) 2000-11-09
DE60042078D1 (de) 2009-06-04

Similar Documents

Publication Publication Date Title
ATE429245T1 (de) Durch mycobacterium tuberculosis und nicht durch bcg exprimierte proteine und ihre verwendung als diagnostische reagenzien und impfstoffe
DK1645631T3 (da) Neisseria antigener og præparater
WO2000066067A3 (en) Ibd-associated microbial antigens and methods of using same
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
WO2002032925A3 (en) Protein scaffolds for antibody mimics and other binding proteins
AU3948801A (en) Heterologous expression of neisserial proteins
ATE293159T1 (de) Stabilisierendes verdünnungsmittel für polypeptide und antigene
DE60124899D1 (de) Durch mage minigene kodierte immunogene polypeptide und ihre verwendungen
SG158141A1 (en) Pancreatic polypeptide family motifs, polypeptides and methods comprising the same
DE60042430D1 (de) An menschlichen Faktor-VIII bindende Moleküle und Faktor-VIII-ähnliche Proteine
ATE277171T1 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
TR200003467T2 (tr) Neisseria meningitidis antijenik polipeptidler, mütekabil polinükleotidler ve koruyucu antikorlar
Lacayo William Levitt.
WO2000066143A8 (en) Secreted proteins of mycobacterium tuberculosis and their use as vaccines and diagnostic reagents
DE69935323D1 (de) Moraxella catharralis proteine
DE60120357D1 (de) Haemophilus influenza äusseres membranprotein und verwendung davon als impstoff
FR2826392B1 (fr) Dispositif d'assemblage des bords de panneaux, lattes ou lambris
WO2001092305A3 (en) Mammalian transforming growth factor beta-10
Jaidka Device for controlling air pollution
HU9902267D0 (en) Mv tamara variety of wheat (triticum aestivum l.)
ATE414717T1 (de) Neuromedin u delta polypeptide
DE60238243D1 (de) Polypeptide, abgeleitet von der amyloid vorläuferprotein (app), und ihre verwendungen
ITRM20010257A0 (it) Procedimento per la rinaturazione, idrolisi e produzione di proteine pr ricombinanti, composizioni e kit utilizzabili in tali procedimenti.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1214088

Country of ref document: EP